IN8bio, Inc.
INAB · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $9,847 | $8,609 | $415,741 | $559,571 |
| - Cash | $10,689 | $13,226 | $11,888 | $11,120 |
| + Debt | $2,957 | $3,118 | $4,272 | $5,030 |
| Enterprise Value | $2,115 | -$1,499 | $408,125 | $553,481 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$3,327 | -$4,417 | -$4,991 | -$5,522 |
| % Margin | – | – | – | – |
| Net Income | -$3,854 | -$5,094 | -$5,550 | -$6,160 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.85 | -1.24 | -0.067 | -0.085 |
| % Growth | 31.5% | -1,764.7% | 21.8% | – |
| Operating Cash Flow | -$3,524 | -$3,927 | -$3,122 | -$4,028 |
| Capital Expenditures | $0 | $0 | $0 | -$33 |
| Free Cash Flow | -$3,524 | -$3,927 | -$3,122 | -$4,061 |